S. Vožeh

1.3k total citations
45 papers, 997 citations indexed

About

S. Vožeh is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Analytical Chemistry. According to data from OpenAlex, S. Vožeh has authored 45 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Pediatrics, Perinatology and Child Health and 10 papers in Analytical Chemistry. Recurrent topics in S. Vožeh's work include Pharmaceutical studies and practices (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Analytical Methods in Pharmaceuticals (10 papers). S. Vožeh is often cited by papers focused on Pharmaceutical studies and practices (14 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Analytical Methods in Pharmaceuticals (10 papers). S. Vožeh collaborates with scholars based in Switzerland, United Kingdom and France. S. Vožeh's co-authors include Ferenc Folláth, Markus R. Wenk, J. Robert Powell, Sidney Riegelman, Leon Aarons, Lewis B. Sheiner, Olga Schmidlin, John Costello, P C Hopewell and LN Sansom and has published in prestigious journals such as The Lancet, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

S. Vožeh

41 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Vožeh Switzerland 18 265 247 244 184 140 45 997
A. W. Kelman United Kingdom 21 255 1.0× 202 0.8× 131 0.5× 89 0.5× 317 2.3× 73 1.6k
Theodor W. Guentert Switzerland 19 244 0.9× 174 0.7× 394 1.6× 74 0.4× 85 0.6× 40 1.1k
Andrew W. Kelman United Kingdom 17 108 0.4× 129 0.5× 100 0.4× 176 1.0× 121 0.9× 27 1.4k
K.C. Kwan United States 17 503 1.9× 175 0.7× 316 1.3× 62 0.3× 107 0.8× 33 1.5k
E Diletti Germany 12 129 0.5× 175 0.7× 126 0.5× 302 1.6× 62 0.4× 18 841
Donald Perrier United States 23 358 1.4× 341 1.4× 304 1.2× 39 0.2× 92 0.7× 53 1.6k
B. Whiting United Kingdom 28 492 1.9× 460 1.9× 294 1.2× 301 1.6× 256 1.8× 100 2.3k
Richard L. Lalonde United States 17 117 0.4× 159 0.6× 166 0.7× 77 0.4× 57 0.4× 32 695
Renato L. Galeazzi Switzerland 16 371 1.4× 249 1.0× 243 1.0× 35 0.2× 98 0.7× 45 1.6k
William G. Crouthamel United States 17 325 1.2× 143 0.6× 134 0.5× 44 0.2× 73 0.5× 30 1.2k

Countries citing papers authored by S. Vožeh

Since Specialization
Citations

This map shows the geographic impact of S. Vožeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vožeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vožeh more than expected).

Fields of papers citing papers by S. Vožeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Vožeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vožeh. The network helps show where S. Vožeh may publish in the future.

Co-authorship network of co-authors of S. Vožeh

This figure shows the co-authorship network connecting the top 25 collaborators of S. Vožeh. A scholar is included among the top collaborators of S. Vožeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Vožeh. S. Vožeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vožeh, S., et al.. (1999). Drug-drug interactions of new active substances: mibefradil example. European Journal of Clinical Pharmacology. 55(8). 559–565. 67 indexed citations
2.
Kaufmann, Gilbert R., S. Vožeh, Markus R. Wenk, & Walter E. Haefeli. (1998). Safety and Efficacy of a Two-Compartment Bayesian Feedback Program for Therapeutic Tobramycin Monitoring in the Daily Clinical Use and Comparison With a Non-Bayesian One-Compartment Model. Therapeutic Drug Monitoring. 20(2). 172–180. 6 indexed citations
3.
Aarons, Leon, Malcolm Rowland, L. P. Balant, et al.. (1996). Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. European Journal of Clinical Pharmacology. 49(4). 251–254. 44 indexed citations
4.
Aarons, Leon, L. P. Balant, P. L. Morselli, et al.. (1994). Population approaches in drug development. European Journal of Clinical Pharmacology. 46(5). 389–91. 21 indexed citations
5.
Balant, L. P., Malcolm Rowland, Leon Aarons, et al.. (1993). New strategies in drug development and clinical evaluation: the population approach. European Journal of Clinical Pharmacology. 45(2). 93–94. 49 indexed citations
6.
Schmidlin, Olga, S. Vožeh, B T Keller, André P. Perruchoud, & Ferenc Folláth. (1990). Predictability and intraindividual variability of serum theophylline concentrations in patients with obstructive lung disease: 12-h versus 24-h dosing. European Journal of Clinical Pharmacology. 39(3). 253–256. 1 indexed citations
7.
Vožeh, S., Walter E. Haefeli, Heonjoo Ha, Jiřı́ Vlček, & Ferenc Folláth. (1990). Nonlinear kinetics of propafenone metabolites in healthy man. European Journal of Clinical Pharmacology. 38(5). 509–513. 25 indexed citations
8.
Vožeh, S., et al.. (1989). Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.. PubMed. 297. 29–38. 1 indexed citations
9.
Vožeh, S., et al.. (1988). Pharmacokinetic Drug Data1. Clinical Pharmacokinetics. 15(4). 254–282. 61 indexed citations
10.
Wenk, Markus R., Elı́sio Costa, Markus Zuber, et al.. (1988). PHARMACOKINETICS OF CYCLOSPORINE G IN PATIENTS WITH RENAL FAILURE. Transplantation. 45(3). 558–561. 9 indexed citations
11.
Vožeh, S., et al.. (1987). Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.. Journal of Pharmacology and Experimental Therapeutics. 243(1). 297–301. 7 indexed citations
12.
Mikus, Gerd, Heonjoo Ha, S. Vožeh, et al.. (1986). Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine. European Journal of Clinical Pharmacology. 31(1). 69–72. 36 indexed citations
13.
Ha, Heonjoo, S. Vožeh, & F. Follath. (1986). Evaluation of a Rapid Ultrafiltration Technique for Determination of Quinidine Protein Binding and Comparison with Equilibrium Dialysis. Therapeutic Drug Monitoring. 8(3). 331–335. 9 indexed citations
14.
Vožeh, S., R. Tyler Hillman, Michael Wandell, Thomas M. Ludden, & Lewis B. Sheiner. (1985). Computer-Assisted Drug Assay Interpretation Based on Bayesian Estimation of Individual Pharmacokinetics. Therapeutic Drug Monitoring. 7(1). 66–73. 20 indexed citations
15.
Ha, Heonjoo, S. Vožeh, & Ferenc Folláth. (1984). Measurement of Free Lidocaine Serum Concentration by Equilibrium Dialysis and Ultrafiltration Techniques. Clinical Pharmacokinetics. 9(Supplement 1). 96–96. 7 indexed citations
16.
Folláth, Ferenc, R Ritz, S. Vožeh, & Markus R. Wenk. (1982). [Slower lidocaine elimination and dose adjustment in patients with heart failure].. PubMed. 112(22). 789–91. 1 indexed citations
17.
Vožeh, S.. (1981). [Pharmacokinetic of benzodiazepines in old age].. PubMed. 111(47). 1789–93. 5 indexed citations
18.
Kewitz, G, et al.. (1981). [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy].. PubMed. 111(52). 2054–6. 1 indexed citations
19.
Powell, J. Robert, J. F. Thiercelin, S. Vožeh, LN Sansom, & Sidney Riegelman. (1977). The influence of cigarette smoking and sex on theophylline disposition.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 116(1). 17–23. 97 indexed citations
20.
Vožeh, S., et al.. (1975). [Proceedings: Studies on the digoxin resorption in patients with decompensated right cardiac insufficiency].. PubMed. 105(51). 1782–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. W. Kelman Breakdown of academic impact, for papers by Theodor W. Guentert Breakdown of academic impact, for papers by Andrew W. Kelman Breakdown of academic impact, for papers by K.C. Kwan Breakdown of academic impact, for papers by E Diletti Breakdown of academic impact, for papers by Donald Perrier Breakdown of academic impact, for papers by B. Whiting Breakdown of academic impact, for papers by Richard L. Lalonde Breakdown of academic impact, for papers by Renato L. Galeazzi Breakdown of academic impact, for papers by William G. Crouthamel
Rankless by CCL
2026